Scholarlink

Background <p>This study aimed to evaluate the association between AO/OTA subclassification and treatment selection in intertrochanteric femur fractures and to determine how closely real-world clinical decisions align with classification-based recommendations.</p> Methods <p>A retrospective analysis was performed on 474 patients treated for intertrochanteric femur fractures between 2015 and 2020. Fractures were subclassified according to AO/OTA 31-A classification using standard radiographs. Chi-square tests with Cramer’s V were used to assess the relationship between fracture groups and treatment modalities. Multinomial logistic regression evaluated predictors of treatment choice, while guideline adherence was analyzed using binary logistic regression. A p value &lt; 0.05 was considered statistically significant.</p> Results <p>PFN was the most frequently applied treatment (74.1%), followed by conservative management (13.5%) and DHS (5.7%). Treatment distribution differed significantly among AO/OTA groups (χ<sup>2</sup> = 40.408, <i>p</i> &lt; 0.001; Cramer’s V = 0.206). AO/OTA group independently predicted treatment selection (<i>p</i> = 0.002), whereas age (<i>p</i> = 0.179) and sex (<i>p</i> = 0.579) did not independently predict treatment selection. The regression model explained 8–10% of treatment variance (Nagelkerke R<sup>2</sup> = 0.097). Guideline adherence was 79.3%, with no independent predictors of non-adherence. Additionally, the 95% confidence intervals for regression coefficients crossed 1 for all variables (age: 0.947–1.016; sex: 0.570–1.483; AO group: 0.592–1.199), confirming that none independently predicted adherence. Conservative treatment was relatively frequent due to the cohort’s advanced age and comorbidity burden. Revision surgery occurred in 3.8% of cases.</p> Conclusions <p>Although AO/OTA subclassification significantly influences treatment choice, fracture morphology alone is insufficient for determining management. PFN remains preferred across fracture types, while non-operative care is suitable for high-risk patients. Future models should integrate frailty, bone quality, and functional status.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Concordance of surgical treatment with AO/OTA subclassification in intertrochanteric femoral fractures

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月8日

查看全文
  • Yüksel Topkaya,
  • Vadym Zhamilov,
  • Özgür Uslu,
  • Yunus Emre Özdemir,
  • Ali Arslan,
  • Doğuş Turgut Kocadağ,
  • Büşra Emir

摘要

Background

This study aimed to evaluate the association between AO/OTA subclassification and treatment selection in intertrochanteric femur fractures and to determine how closely real-world clinical decisions align with classification-based recommendations.

Methods

A retrospective analysis was performed on 474 patients treated for intertrochanteric femur fractures between 2015 and 2020. Fractures were subclassified according to AO/OTA 31-A classification using standard radiographs. Chi-square tests with Cramer’s V were used to assess the relationship between fracture groups and treatment modalities. Multinomial logistic regression evaluated predictors of treatment choice, while guideline adherence was analyzed using binary logistic regression. A p value < 0.05 was considered statistically significant.

Results

PFN was the most frequently applied treatment (74.1%), followed by conservative management (13.5%) and DHS (5.7%). Treatment distribution differed significantly among AO/OTA groups (χ2 = 40.408, p < 0.001; Cramer’s V = 0.206). AO/OTA group independently predicted treatment selection (p = 0.002), whereas age (p = 0.179) and sex (p = 0.579) did not independently predict treatment selection. The regression model explained 8–10% of treatment variance (Nagelkerke R2 = 0.097). Guideline adherence was 79.3%, with no independent predictors of non-adherence. Additionally, the 95% confidence intervals for regression coefficients crossed 1 for all variables (age: 0.947–1.016; sex: 0.570–1.483; AO group: 0.592–1.199), confirming that none independently predicted adherence. Conservative treatment was relatively frequent due to the cohort’s advanced age and comorbidity burden. Revision surgery occurred in 3.8% of cases.

Conclusions

Although AO/OTA subclassification significantly influences treatment choice, fracture morphology alone is insufficient for determining management. PFN remains preferred across fracture types, while non-operative care is suitable for high-risk patients. Future models should integrate frailty, bone quality, and functional status.